A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells

作者: Tameka A Bailey , Haitao Luan , Eric Tom , Timothy Alan Bielecki , Bhopal Mohapatra

DOI: 10.1074/JBC.M114.608992

关键词: PhosphorylationCell biologyEndocytic recyclingKinaseProtein kinase CReceptor tyrosine kinaseEndocytic cycleHsp90 inhibitorBiologyEndosome

摘要: ErbB2 overexpression drives oncogenesis in 20–30% cases of breast cancer. Oncogenic potential is linked to inefficient endocytic traffic into lysosomes and preferential recycling. However, regulation recycling incompletely understood. We used a high-content immunofluorescence imaging-based kinase inhibitor screen on SKBR-3 cancer cells identify kinases whose inhibition alters the clearance cell surface induced by Hsp90 17-AAG. Less was observed with broad-spectrum PKC Ro 31-8220. A similar effect Go 6976, selective classical Ca2+-dependent PKCs (α, β1, βII, γ). activation PMA promoted but without degradation, move juxtanuclear compartment where it colocalized PKC-α PKC-δ together regulator Arf6. knockdown impaired localization ErbB2. transit also upon knockdown. PMA-induced Erk phosphorylation reduced lapatinib, as well not that PKC-α. Our results suggest -δ mediates novel positive feedback loop promoting entry compartment, consistent reported roles for these ErbB2-mediated tumorigenesis. As compartment/pericentrion has emerged PKC-dependent signaling hub G-protein-coupled receptors, our findings raise possibility involves previously unexplored endosomal signaling.

参考文章(115)
Lily Zeng, Samuel V. Webster, Philip M. Newton, The Biology of Protein Kinase C Advances in Experimental Medicine and Biology. ,vol. 740, pp. 639- 661 ,(2012) , 10.1007/978-94-007-2888-2_28
C. R. King, I. Borrello, F. Bellot, P. Comoglio, J. Schlessinger, Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. The EMBO Journal. ,vol. 7, pp. 1647- 1651 ,(1988) , 10.1002/J.1460-2075.1988.TB02991.X
Takako Kaneko, Akio Maeda, Mikito Takefuji, Hiroki Aoyama, Masanori Nakayama, Saeko Kawabata, Yoji Kawano, Akihiro Iwamatsu, Mutsuki Amano, Kozo Kaibuchi, Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin A1 by Rho-kinase Genes to Cells. ,vol. 10, pp. 973- 987 ,(2005) , 10.1111/J.1365-2443.2005.00895.X
Swee Sharp, Paul Workman, Inhibitors of the HSP90 molecular chaperone: current status. Advances in Cancer Research. ,vol. 95, pp. 323- 348 ,(2006) , 10.1016/S0065-230X(06)95009-X
Sara McKenzie, Robert C. Bast, Lisa A. Maier, Cinda M. Boyer, Susan Hester, Yair Argon, Arthur M. Bruskin, Feng Ji Xu, Requirements for the Internalization of a Murine Monoclonal Antibody Directed against the HER-2/neu Gene Product c-erbB-2 Cancer Research. ,vol. 51, pp. 5361- 5369 ,(1991)
Daniel Harari, Yosef Yarden, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. ,vol. 19, pp. 6102- 6114 ,(2000) , 10.1038/SJ.ONC.1203973
L. M. Friedman, A. Rinon, B. Schechter, L. Lyass, S. Lavi, S. S. Bacus, M. Sela, Y. Yarden, Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy Proceedings of the National Academy of Sciences. ,vol. 102, pp. 1915- 1920 ,(2005) , 10.1073/PNAS.0409610102
Srikumar M Raja, Robert J Clubb, Mitra Bhattacharyya, Manjari Dimri, Hao Cheng, Wei Pan, Cesar Ortega-Cava, Alagarsamy Lakku-Reddi, Mayumi Naramura, Vimla Band, Hamid Band, None, A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biology & Therapy. ,vol. 7, pp. 1630- 1640 ,(2008) , 10.4161/CBT.7.10.6585
Xiao-Li Yang, Yang Z. Huang, Wen C. Xiong, Lin Mei, Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors. Molecular and Cellular Neuroscience. ,vol. 28, pp. 335- 346 ,(2005) , 10.1016/J.MCN.2004.10.001